BEYOND THE MANDATE: WHAT PEOS SHOULD EVALUATE IN FERTILITY BENEFITS

For many PEOs and their clients, fertility benefits are moving from a specialized offering to a more regular part of benefits discussions.

For small and mid-sized employers, the conversation often begins with a few basic questions:

• Does the medical plan cover in vitro fertilization (IVF) and other fertility services?
• Does a state mandate apply?
• What options are available when an employer is not subject to a mandate?
• Are fertility medications included?

Those questions matter, but they don’t tell the full story.

The fertility policy landscape continues to evolve at both the state and federal levels. States are taking different approaches to infertility treatment, fertility preservation, eligibility, nondiscrimination, assisted reproductive technology, and family building. Some legislative activity focuses on expanding insurance coverage, while other proposals address access to treatment, embryo policy, or gestational carrier arrangements.

For PEOs advising clients across markets, the focus should be on what fertility coverage means in practice: who can access it, how care is delivered, and whether the benefit supports quality and cost sustainability.

A MANDATE DOES NOT CREATE A UNIFORM BENEFIT

There is no single model for state fertility requirements. Depending on the state and type of coverage involved, requirements may differ in who is eligible, what services are included, how infertility is defined, whether fertility preservation is covered, and whether treatment limits or other restrictions apply.

Recent state activity illustrates that variation. Proposals have addressed fertility preservation, the number of egg retrievals or embryo transfers, fertility medications, tissue storage, nondiscrimination protections, and access to assisted reproductive technology.

Applicability can also depend on how coverage is funded and structured. Fully insured coverage may be subject to applicable state insurance requirements, while self-funded employer health plans are generally governed by federal law under ERISA rather than state insurance benefit mandates. PEO arrangements can add another layer of complexity, making it important to understand the specific plan structure and applicable requirements.

Even when a mandate does not apply, legislative activity can signal broader market direction. Expanding fertility coverage, nondiscrimination protections, and family building access are increasingly part of benefits discussions, giving employers reason to evaluate their approach beyond minimum compliance.

Because requirements continue to change, qualified benefits and legal advisers remain important partners in evaluating the rules applicable to a particular client and plan.

LOOK BEYOND THE PRICE OF TREATMENT

Affordability is another important part of the discussion. For PEOs and their clients, the financial question extends beyond the price of an individual IVF cycle or fertility medication. It also includes how coverage is funded, how risk is managed, and how predictable the employer’s financial exposure will be.

A specialized fertility benefits partner can help bring together considerations such as provider quality, treatment patterns, pharmacy coordination, utilization, and benefit design. That expertise may help employers make more informed decisions about both care and total cost.

A fertility journey may involve diagnostic testing, medications, procedures, monitoring, multiple treatment attempts, and, ultimately, pregnancy and delivery. Benefit design can influence that journey.

When evaluating an approach, consider how providers are assessed, whether the design supports evidence-based treatment decisions, how fertility medications are coordinated with medical care, and what information is available about outcomes and utilization.

Treatment practices can also have downstream implications. Multiple gestation pregnancies, for example, can involve greater clinical complexity, making appropriate embryo-transfer practices relevant to both outcomes and total cost.

The goal is not to limit medically appropriate care. It is to evaluate whether the benefit supports high-quality decision-making and effective, efficient treatment for each individual journey.

FIVE AREAS TO EXAMINE

1. ELIGIBILITY AND ACCESS. Start with who can use the benefit. Does eligibility depend on a particular definition of infertility or prior treatment history? How does the design address people who may need assisted reproduction to build a family but do not meet a traditional infertility definition?

These questions are particularly relevant as policymakers in some states consider expanded definitions of infertility and nondiscrimination protections.

2. SCOPE OF SERVICES. “Fertility coverage” can mean very different things from one plan to another. Examine what is actually included, which may encompass diagnostic services, fertility preservation, intrauterine insemination, IVF, medications, genetic testing, storage, or other family building services.

3. PROVIDER QUALITY AND MEMBER GUIDANCE. Coverage alone does not make fertility care easy to navigate. Consider whether members can identify appropriate providers, understand their benefits and authorization requirements, and get knowledgeable support when questions arise.

4. MEDICAL AND PHARMACY COORDINATION. Fertility medications are closely tied to treatment protocols, even when medical and pharmacy benefits are administered separately. Understanding how authorizations, medication quantities, delivery, and treatment plans are coordinated can reveal important gaps in the member experience.

5. OUTCOMES, REPORTING, AND FINANCIAL FIT. Employers need to understand whether a benefit is delivering value and how it may affect overall benefits spend. That means looking at available clinical and utilization information, how outcomes are measured, how financial risk is structured, and whether the approach provides an appropriate level of cost predictability.

For small and mid-sized employers, understanding both expected cost and exposure to higher-cost cases can be an important part of the decision.

HELPING CLIENTS CONNECT THE PIECES

PEOs do not need to become fertility clinicians or legislative experts. Their value is in helping clients connect decisions that can otherwise become fragmented across medical coverage, pharmacy, compliance, finance, and employee experience.

Benefit reviews, RFPs, and renewals provide an opportunity to look beyond a coverage checklist. Where does fertility treatment currently sit within the benefits package? How are medications handled? Are there gaps between having coverage and being able to access it? What information will the employer receive about utilization, outcomes, and cost?

Communication matters too. Employees may be trying to understand eligibility requirements, medical benefits, pharmacy coverage, and next steps while making significant personal healthcare decisions.

The fertility landscape will continue to change. Building a strategy around any single mandate or legislative moment is unlikely to be enough.

A more durable approach is to evaluate fertility benefits across five dimensions: access, quality, coordination, outcomes, and financial sustainability. That gives PEOs a consistent framework for helping clients make informed decisions, even as the regulatory environment evolves.

This article is designed to give general and timely information about the subjects covered. It is not intended as legal advice, medical advice, or assistance with individual problems. Readers should consult competent counsel of their own choosing about how the matters relate to their own affairs.